DEPLOYThe reference layer for physical AI

Robot model

Samsung Galaxy Watch (and Galaxy Ring)

Samsung Electronics' Galaxy Watch and Galaxy Ring are biometric-primary devices with FDA-cleared cardiac and sleep AI on the Watch, recorded in the new biometric form factor. The Galaxy Watch 7 and Watch Ultra, both from July 2024, carry a BioActive sensor combining optical heart-rate, electrical ECG, and bioimpedance sensing, while the Galaxy Ring announced in July 2024 carries an accelerometer, optical heart-rate, and skin-temperature sensor for sleep, heart rate, and an Energy Score but has no ECG and no FDA-cleared medical features. The Watch's clearances, held through the Samsung Health Monitor app, are an on-demand ECG cleared in 2021, an Irregular Heart Rhythm Notification for atrial fibrillation announced in May 2023, and a sleep-apnea feature authorized via FDA De Novo on February 9, 2024 as the first such feature authorized by the FDA, for moderate-to-severe obstructive sleep apnea in adults 22 and older. A significant cap-flag applies to blood pressure: the Galaxy Watch's cuff-calibrated blood-pressure feature was available internationally for years but not FDA-cleared in the US, and when Samsung launched it to US users around March 31, 2026 it did so explicitly without FDA clearance under the agency's general-wellness low-risk-device policy, so it is a wellness carve-out rather than a medical clearance and marketing it as medical-grade blood pressure exceeds its regulatory status, while the Galaxy Ring carries no FDA-cleared medical features and should not be conflated with the Watch's clearances. The devices are sold by hardware purchase with no subscription, Samsung's clinical-validation posture is growing with a strong regulatory record but thinner independent peer-review than Apple, and the exact clearance number for the atrial-fibrillation feature and whether the US blood-pressure wellness launch will later pursue FDA clearance are not verified.

Samsung Galaxy Watch (and Galaxy Ring) is a biometric robot built by Samsung Electronics.

Machine-readable surfaces

Form factor
biometric
Maturity stage
commercial
Lifecycle
active
Deployments
0
ID
df95c54f-78bf-4e3d-a232-80c8385c6e1d

Specs

notes
[object Object],[object Object],[object Object]
specs
Galaxy Watch 7 + Watch Ultra (Jul 2024) + Galaxy Ring (Jul 2024). Watch BioActive sensor (optical HR + electrical ECG + bioimpedance). Galaxy Ring: accelerometer + optical HR + skin temp (sleep/HR/Energy Score; NO ECG, NO FDA-cleared features). Health features via Samsung Health Monitor app (holds the FDA clearances). Hardware purchase; NO subscription.
formFactor
biometric (biometric-primary smartwatch + smart ring; FDA-cleared cardiac/sleep AI on the Watch)

Supply chain

No verified supply relationships on file. Supply-chain coverage is being added across the registry; check back as the seed populates this model’s suppliers.

Suppliers appear here when verified with at least two strong sources (maker-official / IR / regulatory / standards-body / verified tier-2). Sources are append-only; corrections add new sources rather than rewrite history.

Sources (4)

  1. https://aasm.org/samsung-galaxy-watch-sleep-apnea-feature-receives-fda-authorization/
  2. https://techcrunch.com/2023/05/08/samsungs-irregular-heart-rhythm-notification-galaxy-watch-fda-clearance/
  3. https://www.androidauthority.com/samsung-galaxy-watch-blood-pressure-monitoring-us-rollout-3653403/
  4. https://www.mobihealthnews.com/news/samsung-announces-new-galaxy-ring-and-galaxy-watch-ultra

Common questions

What is Samsung Galaxy Watch (and Galaxy Ring)?
Samsung Electronics' Galaxy Watch and Galaxy Ring are biometric-primary devices with FDA-cleared cardiac and sleep AI on the Watch, recorded in the new biometric form factor. The Galaxy Watch 7 and Watch Ultra, both from July 2024, carry a BioActive sensor combining optical heart-rate, electrical ECG, and bioimpedance sensing, while the Galaxy Ring announced in July 2024 carries an accelerometer, optical heart-rate, and skin-temperature sensor for sleep, heart rate, and an Energy Score but has no ECG and no FDA-cleared medical features. The Watch's clearances, held through the Samsung Health Monitor app, are an on-demand ECG cleared in 2021, an Irregular Heart Rhythm Notification for atrial fibrillation announced in May 2023, and a sleep-apnea feature authorized via FDA De Novo on February 9, 2024 as the first such feature authorized by the FDA, for moderate-to-severe obstructive sleep apnea in adults 22 and older. A significant cap-flag applies to blood pressure: the Galaxy Watch's cuff-calibrated blood-pressure feature was available internationally for years but not FDA-cleared in the US, and when Samsung launched it to US users around March 31, 2026 it did so explicitly without FDA clearance under the agency's general-wellness low-risk-device policy, so it is a wellness carve-out rather than a medical clearance and marketing it as medical-grade blood pressure exceeds its regulatory status, while the Galaxy Ring carries no FDA-cleared medical features and should not be conflated with the Watch's clearances. The devices are sold by hardware purchase with no subscription, Samsung's clinical-validation posture is growing with a strong regulatory record but thinner independent peer-review than Apple, and the exact clearance number for the atrial-fibrillation feature and whether the US blood-pressure wellness launch will later pursue FDA clearance are not verified.
Who makes Samsung Galaxy Watch (and Galaxy Ring)?
Samsung Galaxy Watch (and Galaxy Ring) is made by Samsung Electronics, based in Suwon, South Korea, founded in 1969.
Where is Samsung Galaxy Watch (and Galaxy Ring) deployed?
No verified deployments of Samsung Galaxy Watch (and Galaxy Ring) are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.
What is Samsung Galaxy Watch (and Galaxy Ring)'s maturity stage?
Samsung Galaxy Watch (and Galaxy Ring) is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.